您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报 (医学版) ›› 2024, Vol. 62 ›› Issue (3): 61-69.doi: 10.6040/j.issn.1671-7554.0.2024.0057

• 临床医学 • 上一篇    下一篇

单核细胞与淋巴细胞比值动态变化对慢加急性乙型肝炎肝衰竭预后的诊断价值

杨雪彦1,2,吴寅平1,2,吕丽3,赵泽华1,2,马行宇1,2,李凤彩1,2,王凯1,2,范玉琛1,2   

  1. 1.山东大学齐鲁医院肝病科, 山东 济南 250012;2.山东大学肝病研究所, 山东 济南 250012;3.山东大学齐鲁医院预约随访科, 山东 济南 250012
  • 发布日期:2024-05-06
  • 通讯作者: 范玉琛. E-mail:fanyuchen@sdu.edu.cn
  • 基金资助:
    国家自然科学基金(82270631);山东大学临床研究中心急危重症重点专项(2021SDUCRCB006)

Diagnostic value of dynamic changes of monocyte-to-lymphocyte ratio in acute-on-chronic hepatitis B liver failure

YANG Xueyan1,2, WU Yinping1,2, LYU Li3, ZHAO Zehua1,2, MA Hangyu1,2, LI Fengcai1,2, WANG Kai1,2, FAN Yuchen1,2   

  1. 1. Department of Hepatology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China;
    2. Institute of Hepatology, Shandong University, Jinan 250012, Shandong, China;
    3. Department of Outpatient and Follow Up Center, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Published:2024-05-06

PDF (PC)

87

摘要： 目的 研究单核细胞与淋巴细胞比值(monocyte/lymphocyte ratio, MLR)动态变化对慢加急性乙型肝炎肝衰竭(acute-on-chronic hepatitis B liver failure, ACHBLF)患者临床预后的诊断价值。 方法 回顾性纳入2010年1月至2023年7月在山东大学齐鲁医院肝病科住院的ACHBLF患者,平滑曲线拟合与阈值效应分析MLR值与患者30 d死亡风险的非线性关系,Logistic回归分析和Boruta算法评估患者30 d预后的风险因素,受试者工作特征曲线(receiver operating characteristic curve, ROC)评估MLR的诊断价值,Bootstrap法验证MLR的诊断价值。 结果 共纳入ACHBLF患者243例,其中98例患者在30 d内死亡。入院第8天MLR值是患者30 d预后的独立风险因素(OR=1.33, 95%CI:1.01~1.75, P=0.044),与30 d死亡风险呈非线性关系,入院第8天MLR值>1的患者死亡风险高于第8天MLR值≤1的患者(P<0.001)。入院第8天MLR值联合终末期肝病模型(model for end-stage liver disease, MELD)评分诊断30 d患者死亡的ROC曲线下面积为0.775(95%CI: 0.69~0.86)。 结论 入院第8天MLR>1提示ACHBLF患者30 d的预后不良,动态监测MLR的变化有助于ACHBLF的临床诊疗。

关键词: 慢加急性乙型肝炎肝衰竭, 单核细胞与淋巴细胞比值, 预后, 风险因素

Abstract: Objective To explore the diagnostic value of dynamic changes of monocyte/lymphocyte ratio(MLR)in the prognosis of acute-on-chronic hepatitis B liver failure(ACHBLF). Methods The study involved ACHBLF patients from January 2010 to July 2023 in the Department of Hepatology, Qilu Hospital of Shandong University. Smooth curve fitting and threshold effect analysis were used to evaluate the nonlinear relationship between MLR and 30-day mortality of ACHBLF patients. Logistic regression analysis and the Boruta algorithm were used to assess risk factors for 30-day mortality. The receiver operating characteristic(ROC)curve was used to evaluate the diagnostic value of MLR and the bootstrap method was used for internal validation. Results In this study, 98 of the 243 individuals died within 30 days after hospitalization. MLR on the 8th day was identified as an independent risk factor for 30-day mortality of ACHBLF patients(OR=1.33, 95%CI:1.01-1.75, P=0.044), which was reported to be nonlinearly associated with 30-day mortality. Patients with MLR >1 on the 8th day showed a higher risk of mortality than those with MLR≤1(P<0.001). ROC curve showed that combination of MLR on the 8th day and the model for end-stage liver disease(MELD)score presented the area under the ROC of 0.775(95%CI: 0.69-0.86). Conclusion MLR>1 on the 8th day predicts poor 30-day prognosis in ACHBLF patients, and monitoring the dynamic changes of MLR is essential for the treatment of ACHBLF.

Key words: Acute-on-chronic hepatitis B liver failure, Monocyte /lymphocyte ratio, Prognosis, Risk factor

中图分类号: 

  • R575.3
[1] Beech C, Liu C, Zhang X. Pathology of acute and acute-on-chronic liver failure[J]. Clin Liver Dis, 2023, 27(3): 581-593.
[2] Ngu NLY, Flanagan E, Bell S, et al. Acute-on-chronic liver failure: controversies and consensus[J]. World J Gastroenterol, 2023, 29(2): 232-240.
[3] Sarin SK, Choudhury A, Sharma MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver(APASL): an update[J]. Hepatol Int, 2019, 13(4): 353-390.
[4] Br VK, Sarin SK. Acute-on-chronic liver failure: terminology, mechanisms and management[J]. Clin Mol Hepatol, 2023, 29(3): 670-689.
[5] Bhatti TK, Singal AK, Kwo PY. Viral hepatitis and acute-on-chronic liver failure[J]. Clin Liver Dis, 2023, 27(3): 617-630.
[6] Sarin SK, Kedarisetty CK, Abbas Z, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver(APASL)2014[J]. Hepatol Int, 2014, 8(4): 453-471.
[7] Yao J, Liu T, Zhao Q, et al. Genetic landscape and immune mechanism of monocytes associated with the progression of acute-on-chronic liver failure[J]. Hepatol Int, 2023, 17(3): 676-688.
[8] Li J, Liang X, Jiang J, et al. PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF[J]. Gut, 2022, 71(1): 163-175.
[9] Luo J, Li J, Li P, et al. Acute-on-chronic liver failure: far to go-a review[J]. Crit Care, 2023, 27(1): 259.
[10] Zawiah M, Hayat Khan A, Abu Farha R, et al. Neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio, and platelet-lymphocyte ratio in stroke-associated pneumonia: a systematic review and meta-analysis[J]. Curr Med Res Opin, 2023, 39(3): 475-482.
[11] Cheng HR, Song JY, Zhang YN, et al. High monocyte-to-lymphocyte ratio is associated with stroke-associated pneumonia[J]. Front Neurol, 2020, 11: 575809. doi: 10.3389/fneur.2020.575809.
[12] Hu G, Liu G, Ma JY, et al. Lymphocyte-to-monocyte ratio in esophageal squamous cell carcinoma prognosis[J]. Clin Chim Acta, 2018, 486: 44-48. doi: 10.1016/j.cca.2018.07.029.
[13] Hu RJ, Ma JY, Hu G. Lymphocyte-to-monocyte ratio in pancreatic cancer: prognostic significance and meta-analysis[J]. Clin Chim Acta, 2018, 481: 142-146. doi: 10.1016/j.cca.2018.03.008.
[14] Kang Y, Zhu X, Lin Z, et al. Compare the diagnostic and prognostic value of MLR, NLR and PLR in CRC patients[J]. Clin Lab, 2021, 67(9). doi: 10.7754/Clin.Lab.2021.201130.
[15] Hua Y, Sun JY, Lou YX, et al. Monocyte-to-lymphocyte ratio predicts mortality and cardiovascular mortality in the general population[J]. Int J Cardiol, 2023, 379: 118-126. doi: 10.1016/j.ijcard.2023.03.016.
[16] Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance[J]. Hepatology, 2018, 67(4): 1560-1599.
[17] 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2022年版)[J].中华肝脏病杂志, 2022, 30(12): 1309-1331. Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B(version 2022)[J]. Zhonghua Gan Zang Bing Za Zhi, 2022, 30(12): 1309-1331.
[18] Moreau R, Gao B, Papp M, et al. Acute-on-chronic liver failure: a distinct clinical syndrome[J]. J Hepatol, 2021, 75(Suppl 1): S27-S35. doi: 10.1016/j.jhep.2020.11.047.
[19] World Medical Association.World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects[J]. JAMA, 2013, 310(20): 2191-2194.
[20] Ferstl P, Trebicka J. Acute decompensation and acute-on-chronic liver failure[J]. Clin Liver Dis, 2021, 25(2): 419-430.
[21] Zhang Y, Tan W, Wang X, et al. Metabolic biomarkers significantly enhance the prediction of HBV-related ACLF occurrence and outcomes[J]. J Hepatol, 2023, 79(5): 1159-1171.
[22] Jalan R, Williams R. Acute-on-chronic liver failure: pathophysiological basis of therapeutic options[J]. Blood Purif, 2002, 20(3): 252-261.
[23] Jiang F, Lei J, Xiang J, et al. Monocyte-to-lymphocyte ratio: a potential novel predictor for acute kidney injury in the intensive care unit[J]. Ren Fail, 2022, 44(1): 1004-1011.
[24] Wang N, He S, Zheng Y, et al. The value of NLR versus MLR in the short-term prognostic assessment of HBV-related acute-on-chronic liver failure[J]. Int Immunopharmacol, 2023, 121: 110489. doi: 10.1016/j.intimp.2023.110489.
[25] Engelmann C, Zhang IW, Clària J. Mechanisms of immunity in acutely decompensated cirrhosis and acute-on-chronic liver failure[J]. Liver Int, 2023. doi: 10.1111/liv.15644.
[26] Cai J, Wang K, Han T, et al. Evaluation of prognostic values of inflammation-based makers in patients with HBV-related acute-on-chronic liver failure[J]. Medicine(Baltimore), 2018, 97(46): e13324. doi: 10.1097/MD.0000000000013324.
[27] Ruf A, Dirchwolf M, Freeman RB. From child-pugh to MELD score and beyond: taking a walk down memory lane[J]. Ann Hepatol, 2022, 27(1): 100535. doi: 10.1016/j.aohep.2021.100535.
[1] 刁玉洁,林琳,李文瑄,王洲洋,江蓓,胡迎迎,刘广义. NPR预测ANCA相关血管炎不良肾脏预后及其协同多因素优化模型[J]. 山东大学学报 (医学版), 2024, 62(2): 60-68.
[2] 宋兆录,董正璇,彭传真,黄彩娜,胡克清,黄永胜,阎磊. 肾透明细胞癌中预后相关RNA编辑位点的筛选[J]. 山东大学学报 (医学版), 2023, 61(9): 69-78.
[3] 刘艳,冷珊珊,夏晓娜,董昊,黄陈翠,孟祥水. 基于影像组学参数评估376例幕上自发性脑出血患者的功能状态[J]. 山东大学学报 (医学版), 2023, 61(5): 59-67.
[4] 胡立勇,钟浩,房娟娟,国巍,张雨露,范医东. 基于数据库分析CCR基因对肾透明细胞癌预后的预测价值[J]. 山东大学学报 (医学版), 2023, 61(4): 49-55.
[5] 李兆辉,李亮,周飞,郑超,周文重,王斐,余之刚. 乳腺炎性肌纤维母细胞瘤1例及文献回顾[J]. 山东大学学报 (医学版), 2023, 61(4): 121-124.
[6] 陈蓉,杨越,杨智翔,苏亚英,庞智英,王大伟,崔书君,杨飞. 基于CT纹理分析预测急性肺栓塞短期预后[J]. 山东大学学报 (医学版), 2023, 61(12): 78-85.
[7] 华月帆,何珂瑶,张家豪,钱梦凡,刘怡文,孔金玉,杨海军,周福有. 具核梭杆菌诱导缺氧诱导因子及血管生成因子高表达对食管鳞癌患者生存预后的影响[J]. 山东大学学报 (医学版), 2023, 61(11): 59-67.
[8] 赵启迪,王凯,赵小刚,闫涛,王亚东,杜贾军. 基于SEER数据库构建并验证IIIB期非小细胞肺癌患者预后模型[J]. 山东大学学报 (医学版), 2023, 61(10): 23-37.
[9] 郑苏,陈述花,李华,邓劼,陈春红,王晓慧,冯卫星,韩萧迪,张雨佳,李娜,李莫,方方. 脑电变化和BASED评分与54例婴儿痉挛症促肾上腺皮质激素疗效的相关性[J]. 山东大学学报 (医学版), 2022, 60(9): 91-96.
[10] 王丽慧,高敏,孔北华. 子宫血管肉瘤2例报告并文献复习[J]. 山东大学学报 (医学版), 2022, 60(9): 108-112.
[11] 高中霞,张铭,樊明德,谭晨阳,王梦迪,王超,樊跃飞,丁守銮,王成伟. 伽玛刀治疗81例肺癌脑转移瘤的疗效及预后因素[J]. 山东大学学报 (医学版), 2022, 60(8): 44-49.
[12] 贺士卿,李皖皖,董书晴,牟婧怡,刘宇莹,魏思雨,刘钊,张家新. 基于数据库构建乳腺癌焦亡相关基因的预后风险模型[J]. 山东大学学报 (医学版), 2022, 60(8): 34-43.
[13] 张玉凤,徐敏,邢秀丽,逄曙光,户克庆. 689例非ST段抬高型心肌梗死患者的临床流行病学特征[J]. 山东大学学报 (医学版), 2022, 60(7): 118-122.
[14] 李琳琳,王凯. 基于生物信息学预测肝细胞癌预后基因[J]. 山东大学学报 (医学版), 2022, 60(5): 50-58.
[15] 郑昊天,王光辉,赵小刚,王亚东,曾榆凯,杜贾军. 基于数据库LKB1突变肺腺癌DNA异常甲基化位点构建的预后风险模型[J]. 山东大学学报 (医学版), 2022, 60(3): 51-58.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 史爽,李娟,米琦,王允山,杜鲁涛,王传新. 胃癌miRNAs预后风险评分模型的构建与应用[J]. 山东大学学报 (医学版), 2020, 1(7): 47 -52 .
[2] 李新钢,张鑫,陈安静. 当代脑计划研究进展[J]. 山东大学学报 (医学版), 2020, 1(8): 5 -9, 21 .
[3] 尹义龙,袭肖明,孟宪静. 阿尔兹海默病的智能诊断方法[J]. 山东大学学报 (医学版), 2020, 1(8): 14 -21 .
[4] 刘树伟,娄云霞,汤煜春. 4D数字脑图谱的构建、不对称性及遗传倾向[J]. 山东大学学报 (医学版), 2020, 1(8): 28 -33 .
[5] 王剑,周文婧,薛知易,刘晓菲. 脑胶质母细胞瘤模型研究概况及类脑模型的研发应用[J]. 山东大学学报 (医学版), 2020, 1(8): 74 -80 .
[6] 吴刚, 王世隆, 段笑然, 汪洋, 张洪川. 外侧入路关节镜辅助微创距下关节融合[J]. 山东大学学报 (医学版), 2020, 1(8): 107 -114 .
[7] 韩婷, 杜菁, 于佳莉, 郑文舟, 王燕. 47例撕脱性损伤恒牙再植后牙根吸收的影响因素分析[J]. 山东大学学报 (医学版), 2020, 1(8): 115 -119 .
[8] 肖宇飞,冯佳宁,王晓璇,毛倩,石福艳,王素珍. 利用数据库数据采用联合模型动态预测312例肝硬化患者预后的观察分析[J]. 山东大学学报 (医学版), 2020, 1(9): 71 -76 .
[9] 程宝泉,谢英慧,刘春涛,钟宁,樊薇,张尚忠. 慢性乙型病毒性肝炎、肝癌组织HLAⅠ类抗原的表达及意义[J]. 山东大学学报(医学版), 2006, 44(4): 357 -359 .
[10] 黄飞,王怀经,邢毅,高薇,李永刚,邢子英,李振中. NGF和GM1联合应用对坐骨神经损伤大鼠初级传入神经元的保护作用[J]. 山东大学学报(医学版), 2006, 44(4): 332 -335 .
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发